| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
7e-11 |
| mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
1e-08 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-08 |
| mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
8e-08 |
| mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-07 |
| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-07 |
| mRNA |
manumycin A |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
5e-07 |
| mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
6e-07 |
| mRNA |
WZ3105 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
9e-07 |
| mRNA |
BMS-345541 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
1e-06 |